Cardiology

Filter

New Research into Oral Semaglutide and Heart Failure Outcomes

February 2026

The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.

Advancing Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is an inherited disorder that may cause disabling and potentially life-threatening symptoms related to…

Analysis of the Interaction Between Cardiovascular Diseases and Haematological Malignancies

Ablation of cardiac arrhythmias in children under 18 years of age without the use of fluoroscopy is an effective procedure, obtaining an…

New Directions in the Management of Atrial Fibrillation

MANAGEMENT of atrial fibrillation (AF) was a prevalent topic at this year’s European Society of Cardiology (ESC) Congress 2024…

Tachyarrhythmia Ablation with Zero Fluoroscopy Technique in Patients Under 18 Years of Age

Ablation of cardiac arrhythmias in children under 18 years of age without the use of fluoroscopy is an effective procedure, obtaining an…

Artificial Intelligence and Digital Biomarkers: A Revolution in Cardiovascular Diagnostics

THIS YEAR, the European Society of Cardiology (ESC) Congress 2024, which took place in London, UK, between 30th August–2nd September….

ESC 2024 Abstract Highlights

The following highlights showcase groundbreaking research in cardiology, spotlighting key abstracts presented at the European Society of…

ESC 2024 Interview: Lis Neubeck

EMJ spoke to Lis Neubeck, Professor of Nursing and Head of Cardiovascular Health, Edinburgh Napier University, UK, at the European Society…

Real-World Evidence of Hypertrophic Cardiomyopathy and Mavacamten

George Cooper is joined by Perry Elliott, Professor of Cardiovascular Medicine at University College London, UK, and Anjali Owens…

Loading posts...

« Previous 1 … 28 29 30 31 32 … 96 Next »